These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 24848364
1. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA). Miguel TT, Gomes KS, Nunes-de-Souza RL. Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364 [Abstract] [Full Text] [Related]
2. Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway. Bertagna NB, Dos Santos PGC, Queiroz RM, Fernandes GJD, Cruz FC, Miguel TT. Pharmacol Rep; 2021 Feb; 73(1):57-72. PubMed ID: 33175366 [Abstract] [Full Text] [Related]
3. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze. Cipriano AC, Gomes KS, Nunes-de-Souza RL. Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334 [Abstract] [Full Text] [Related]
4. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Miguel TT, Nunes-de-Souza RL. Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867 [Abstract] [Full Text] [Related]
6. Anxiogenesis induced by social defeat in male mice: Role of nitric oxide, NMDA, and CRF1 receptors in the medial prefrontal cortex and BNST. Faria MP, Laverde CF, Nunes-de-Souza RL. Neuropharmacology; 2020 Apr; 166():107973. PubMed ID: 32006904 [Abstract] [Full Text] [Related]
8. Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice. Pentkowski NS, Tovote P, Zavala AR, Litvin Y, Blanchard DC, Spiess J, Blanchard RJ. Horm Behav; 2013 Aug; 64(3):519-26. PubMed ID: 23845323 [Abstract] [Full Text] [Related]
9. Pharmacological Manipulation of Corticotropin-Releasing Factor Receptors in the Anterior and Posterior Subregions of the Insular Cortex Differently Affects Anxiety-Like Behaviors in the Elevated Plus Maze in Rats. Lopes LM, Reis-Silva LL, Rodrigues B, Crestani CC. Biomed Res Int; 2024 Aug; 2024():8322844. PubMed ID: 38327803 [Abstract] [Full Text] [Related]
10. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic. Sergio Tde O, Spiacci A, Zangrossi H. Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701 [Abstract] [Full Text] [Related]
11. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA. Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406 [Abstract] [Full Text] [Related]
12. Microinjection of different doses of corticotropin-releasing factor into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats. Ohata H, Shibasaki T. J Nippon Med Sch; 2011 Nov; 78(5):286-92. PubMed ID: 22041875 [Abstract] [Full Text] [Related]
13. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Sahuque LL, Kullberg EF, Mcgeehan AJ, Kinder JR, Hicks MP, Blanton MG, Janak PH, Olive MF. Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282 [Abstract] [Full Text] [Related]
14. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats. Solati J, Salari AA, Bakhtiari A. Neurosci Lett; 2011 Oct 31; 504(3):325-9. PubMed ID: 21982809 [Abstract] [Full Text] [Related]
15. A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex. Śmiałowska M, Zięba B, Domin H. Neuropeptides; 2021 Aug 31; 88():102162. PubMed ID: 34062382 [Abstract] [Full Text] [Related]
18. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L. Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544 [Abstract] [Full Text] [Related]
19. Corticotropin-releasing factor infusion into nucleus incertus suppresses medial prefrontal cortical activity and hippocampo-medial prefrontal cortical long-term potentiation. Farooq U, Rajkumar R, Sukumaran S, Wu Y, Tan WH, Dawe GS. Eur J Neurosci; 2013 Aug 26; 38(4):2516-25. PubMed ID: 23668693 [Abstract] [Full Text] [Related]
20. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. Ji G, Neugebauer V. J Neurophysiol; 2008 Mar 26; 99(3):1201-12. PubMed ID: 18171711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]